Opioids today: From pharmacology to crisis management and emerging solutions

Bijal Dharmesh Shah *, Ronak Prakashchandra Gandhi, Darshan Narendra Lalwani, Pratik Sanjeev Bankhele and Priyanka Dattatraya Pathak

Independent Researcher, Washington, District of Columbia, The United States of America.
 
Review
World Journal of Biology Pharmacy and Health Sciences, 2024, 20(03), 677-686.
Article DOI: 10.30574/wjbphs.2024.20.3.1030
Publication history: 
Received on 19 October 2024; revised on 16 December 2024; accepted on 18 December 2024
 
Abstract: 
Background: Opioids are a critical component in managing moderate to severe pain, especially in conditions like cancer and post-surgical recovery. However, their use is accompanied by significant risks, including tolerance, dependence, and addiction, which have contributed to a global opioid crisis. The need for safer pain management strategies and regulatory measures has never been more pressing.
Main body: This review provides a comprehensive overview of opioid pharmacology, focusing on the most commonly prescribed opioids and their mechanisms of action. The clinical significance of various routes of administration is examined, highlighting their impact on efficacy and potential for abuse. The ongoing opioid crisis is discussed in detail, tracing its origins to the late 1990s and examining the factors that have exacerbated the problem, including aggressive pharmaceutical marketing and inadequate regulation. Strategies to reduce opioid exposure and prevent new addictions are explored, with a focus on the role of FDA regulatory measures, including updated prescribing guidelines and the development of abuse-deterrent formulations. Recent advancements in opioid research are also highlighted, including the exploration of non-addictive opioids, biased agonism, and targeted drug delivery systems. These innovations offer promise in improving pain management while minimizing the risks associated with opioid use.
Conclusion: The opioid crisis underscores the urgent need for improved pain management practices and safer opioid therapies. Ongoing research and regulatory efforts are critical to addressing these challenges. By integrating recent advancements into clinical practice, we can better balance the need for effective pain relief with the imperative to reduce the risks of addiction and other adverse effects associated with opioid use.
 
Keywords: 
Opioids; Morphine; Fentanyl; Naloxone; Oliceridine
 
Full text article in PDF: